Dr. Ben Lu

Dr. Ben Lu

VP, Xiangya Medical College
Third Xiangya Hospital of Central South University
BioGRAPHY

EDUCATION
Ph.D Clinical medicine, Xiangya Hospital of Central South University 2007-2010
M.D. Internal Medicine, Xiangya School of Medicine, 2001-2007

ACADEMIC EXPERIENCE
Professor and Doctoral Tutor, Physician of Department of Hematology, the 3rd Xiangya Hospital of the Central South University

SOCIAL ACTIVITIES
Assistant Professor at the Feinstein Institute for Medical Research and Hofstra School of Medicine. Chief Scientist of a National 973 Science Project

RESEARCH AREA
The pathogenesis of sepsis and the molecular mechanisms of inflammation

RESEARCH PROJECTS
Received several prestigious grants from Chinese government, including the "One thousand people plan" project, "Excellent Young Investigator Science Fund" and a "Natural Science fund" from the Natural Science Foundation of China.

Speaker's Schedule

Dec 20, 2022
14:40 - 15:00
Hangzhou Talk #6
Programmed cell death and critical illness
Programmed cell death (PCD) is essential for numerous biological processes, such as the development of organs, lymphocyte selection, and host defense against invasive microbes. Accumulated evidence reveal that excessive PCD importantly contributes to the pathogenesis of critical illness, including sepsis, heatstroke, severe viral infection, and cytokine shock syndrome. These life-threatening conditions characterized by multiple organ injuries are the major cause of death in hospital. This review focuses on the roles of PCD in different types of critical illness and the mechanisms by which PCD contributes to the pathogenesis of critical illness. We will also discuss the therapeutic potential of PCD targeting molecules for the treatment of sepsis, an infection-induced critical illness that accounts for more than 11 million deaths ever year in the world.
VIEW HANGZHOU PROGRAM